| Literature DB >> 24558341 |
Ruchira Mukherji1, Asmita Prabhune1.
Abstract
Essential oils (EOs) form an important part of traditional medicine so their anti-microbial and, in the recent past, antiquorum sensing activity has been well studied. However it is likely that due to their hydrophobic nature and reduced solubility in aqueous environments full potential of their activity cannot be realized. hence it is only rational to formulate a process to make these molecules more polar in nature. The present paper reports synthesis of sophorolipids using 12 different essential oils as substrates, thus providing surfactant-like properties to these EOs. The synthesis protocol makes the use of Candida bombicola ATCC 22214 as producer organism. The production process required 7 days of incubation at 28°C and 180 rpm. Preliminary characterization of the synthesized essential oil sophorolipids (EOSLs) was performed using thin layer chromatography (TLC) and Fourier transform infrared spectroscopy (FTIR). Additionally, essential oils that were incapable of mediating quorum sensing inhibition (QSI) on their own became potent quorum sensing inhibitors upon conversion into their corresponding EOSLs. Antibiofilm potential of these EOSLs was also demonstrated using V. cholerae as test organism. Use of essential oils as substrates for glycolipid synthesis has not been attempted previously, and hence this is the first report.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24558341 PMCID: PMC3914375 DOI: 10.1155/2014/890709
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Tabulated data showing quorum sensing inhibitory (QSI) activity of essential oils used in this study, alone and in combination with 10 mg/mL of OASL. Also QSI activity of all synthesized EOSLs.
| Plant essential oil (common name) | Plant essential oil (scientific name) | Main component | Anti-QSI activity of essential oil alone (20% oil) against CV026 (inhibition zone size in mm) | Anti-QSI activity of EO + OASL against CV026 (inhibition zone size in mm)a | Anti-QSI activity of EOSL against CV026 (inhibition zone size in mm)b |
|---|---|---|---|---|---|
| Lemongrass oil |
| Citral | 15 | 28 | 25 |
| Peppermint oil |
| Menthol | — | 16 | 13 |
| Cinnamon oil |
| Cinnamaldehyde | 15 (10% EO) | 20 (10% EO + OASL at 10 mg/mL) | Growth inhibition at 10 mg/mL EOSL. |
| Rosemary oil |
| (+) Alpha pinene | — | — | 13 |
| Basil oil |
| L-Linalool | — | 11 | 30 |
| Bergamot oil |
| L-Linalool | — | — | 17 |
| Eucalyptus oil |
| 1,8-Cineole | — | — | 23 |
| Orange oil |
| Limonene | — | — | 13 |
| Citronella oil |
| Citronellal | — | — | 12 |
| Tea tree oil |
| Alpha terpineol | — | — | 26 |
| Ylang ylang oil |
| L-Linalool | — | 12 | 33 |
| Frankincense oil |
| (+) Alpha pinene | — | — | 17 |
a1 mL reaction mixture contained 20% EO and OASL at a concentration of 10 mg/mL. Also OASL alone used at a concentration of 10 mg/mL had no QSI activity.
bEOSL concentration used 20 mg/mL.
Figure 1TLC analysis of synthesized EOSLs.
Figure 2Oil displacement activity of the synthesized EOSLs.
Figure 3(a) FTIR analysis of the synthesized EOSLs along with OASL. (b) FTIR spectra of EOSLs with composition similar to OASL.
Figure 4Antibiofilm activity of selected EOSLs.